E-LIB Suche - Ergebnisse für: Ferrarini, Isacco

1

Decreased apoptotic priming and loss of BCL-2 dependence ar..:

Rigo, Antonella ; Vaisitti, Tiziana ; Laudanna, Carlo...
Cell Death & Disease. 15 (2024) 5 - p. , 2024

Link: https://doi.org/10.1038/..

2

Extracellular Vesicles based STAT3 delivery as innovative t..:

Bettin, Ilaria ; Brattini, Martina ; Kachoie, Elham Ataie...
New Biotechnology. 82 (2024) - p. 43-53 , 2024

Link: https://doi.org/10.1016/..

3

B-cell receptor signaling activity identifies patients with..:

Gambino, Simona ; Quaglia, Francesca Maria ; Galasso, Marilisa...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Monocyte-to-platelets ratio (MPR) at diagnosis is associate..:

Duminuco, Andrea ; Romano, Alessandra ; Ferrarini, Isacco...
Annals of Hematology. , 2024

Link: https://doi.org/10.1007/..

5

An updated portrait of monocyte-macrophages in classical Ho..:

Ferrarini, Isacco ; Bernardelli, Andrea ; Lovato, Ester...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Case Report: Rapid renal response to venetoclax monotherapy..:

Lovato, Ester ; Gangemi, Concetta ; Krampera, Mauro..
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Continuous venetoclax in treatment‐naive TP53 disrupted pat..:

Visentin, Andrea ; Mauro, Francesca Romana ; Scarfò, Lydia...
American Journal of Hematology. 98 (2023) 9 - p. , 2023

Link: https://doi.org/10.1002/..

8

The mitochondrial anti-apoptotic dependencies of hematologi..:

Ferrarini, Isacco ; Rigo, Antonella ; Visco, Carlo
Haematologica. 107 (2022) 4 - p. 790-802 , 2022

Link: https://doi.org/10.3324/..

9

SARS‐CoV‐2 infection in patients with chronic lymphocytic l..:

Merli, Michele ; Ferrarini, Isacco ; Merli, Francesco...
Hematological Oncology. 41 (2022) 1 - p. 128-138 , 2022

Link: https://doi.org/10.1002/..

10

Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax T..:

Ferrarini, Isacco ; Gandini, Francesca ; Zapparoli, Ettore.
Current Oncology. 29 (2022) 4 - p. 2792-2797 , 2022

Link: https://doi.org/10.3390/..

11

Long‐term benefit of IGHV mutated patients in a real‐life m..:

Moia, Riccardo ; Dondolin, Riccardo ; De Propris, Maria Stefania...
Hematological Oncology. 41 (2022) 3 - p. 567-570 , 2022

Link: https://doi.org/10.1002/..

12

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-..:

Argnani, Lisa ; Broccoli, Alessandro ; Pellegrini, Cinzia...
HemaSphere. 6 (2022) 12 - p. e798 , 2022

Link: https://doi.org/10.1097/..

13

Targeting CD19 in diffuse large B‐cell lymphoma: An expert ..:

Bailly, Sarah ; Cartron, Guillaume ; Chaganti, Sridhar...
Hematological Oncology. 40 (2022) 4 - p. 505-517 , 2022

Link: https://doi.org/10.1002/..

14

Efficacy of R-COMP in comparison to R-CHOP in patients with..:

Visco, Carlo ; Pregnolato, Francesca ; Ferrarini, Isacco...
Critical Reviews in Oncology/Hematology. 163 (2021) - p. 103377 , 2021

Link: https://doi.org/10.1016/..

15

Rituximab and Bendamustine (BR) Compared with Rituximab, Be..:

Bega, Giulia ; Olivieri, Jacopo ; Riva, Marcello...
Cancers. 13 (2021) 23 - p. 6089 , 2021

Link: https://doi.org/10.3390/..